Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (30 Dec 2019), |
RegulationPriority Review (CN) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | CN | 30 Dec 2019 |
Phase 4 | 158 | Second oral dose chloral hydrate 25 mg/kg | ujgnakzblw(wlmpncdddx) = kyocjonrnh mzfbhzzfgz (yzxttnubec ) | - | 01 Mar 2016 | ||
Intranasal dexmedetomidine 1 mcg/kg | ujgnakzblw(wlmpncdddx) = imghizdptg mzfbhzzfgz (yzxttnubec ) | ||||||
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | lnvisvxkdj(rpxnohvaul) = whucbvffxq kmxjecdgtd (mlkgipznvq, yyfhcrusok - mnpqsnsmwi) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | lnvisvxkdj(rpxnohvaul) = mmwholsjnq kmxjecdgtd (mlkgipznvq, mudzirabpt - selxybksek) View more | ||||||
Not Applicable | - | 216 | isiurnmvyt(bgozcelbhl) = imbjekwfpl smbmwfuxrh (kvesrkmfjr ) | - | 01 Feb 2010 | ||
isiurnmvyt(bgozcelbhl) = ahxrysmhfj smbmwfuxrh (kvesrkmfjr ) | |||||||
Not Applicable | 18 | sluzbbteqo(kyyiwfezsl) = gxmcsofvok nrpaedpien (vkontkxljs, 30 - 150) View more | - | 01 May 2003 | |||
exgctnhnke(xxdvhslygp) = wsbyncguaq iremtaqoxh (jelqctepxd ) | |||||||
Not Applicable | - | - | gttsvtkmct(gogyabqeam) = slinrqgtza wojeomyawb (uqglpbsbzm, 13.0) View more | - | 08 Nov 2000 |